Brief: Cleveland Biolabs Q4 Loss Per Share $0.04 Excluding Items
07/03/2019 13:41
March 7 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* Q4 LOSS PER SHARE $0.04 EXCLUDING ITEMS
Source: (http://bit.ly/2IWle1B)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc